Dashboard
Watchlists
Collections
Events
Tools
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
371
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Broker Reports
Sponsored
Refresh
Relevant
bullish
•
Celltrion Inc
•
09 Sep 2023 18:29
Progress of Merger Between Celltrion Inc and Celltrion Healthcare & Appraisal Rights Issue
Although some investors are likely to exercise their appraisal rights in this merger between Celltrion Inc and Celltrion Healthcare, we attach a...
Douglas Kim
505 Views
Share
bullish
•
Celltrion Inc
•
01 Sep 2023 08:51
(Mostly) Asia M&A, Aug 2023: Celltrion Inc/Healthcare, Itochu Techno, UMW, Boustead, SK Rent
For the month of August, 11 new deals were discussed on Smartkarma with an overall deal size of ~US$29bn. The average premium for the new deals...
David Blennerhassett
472 Views
Share
bullish
•
Celltrion Inc
•
20 Aug 2023 07:00
(Mostly) Asia-Pac Weekly Risk Arb Wrap: Celltrion, Sanei Architecture, T&K Toka, MPI, Chindata
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
327 Views
Share
bullish
•
Celltrion Inc
•
17 Aug 2023 18:43
Celltrion Merger: Index Implications
Celltrion and Celltrion Healthcare will merge before the end of the year. Both stocks have dropped and shorts have covered. There will be...
Brian Freitas
557 Views
Share
bullish
•
Celltrion Inc
•
16 Jul 2023 07:00
Last Week in Event SPACE: Celltrion, Fast Retailing, Canon, Costa, Chindata
The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...
David Blennerhassett
361 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.16.5
x